These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20552702

  • 21. Urine peptide patterns for non-invasive diagnosis of endometriosis: a preliminary prospective study.
    Wang L, Liu HY, Shi HH, Lang JH, Sun W.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():23-8. PubMed ID: 24694773
    [Abstract] [Full Text] [Related]

  • 22. [Study on proteomics of familial systemic lupus erythematosus patients in one family from Sichuan, China].
    Wu YK, Huang ZC, Shi YY, Cai B, Wang LL, Ying BW, Hu CJ, Li YZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):504-7, 512. PubMed ID: 19627015
    [Abstract] [Full Text] [Related]

  • 23. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ, Saxby AJ, Nielsen A, Bell C, Samra JS, Hugh T, Baxter RC, Smith RC.
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [Abstract] [Full Text] [Related]

  • 24. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Sep; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 25. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 26. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2015 Feb 15; 10(3):e0119033. PubMed ID: 25816025
    [Abstract] [Full Text] [Related]

  • 27. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L, Hogdall C.
    Acta Obstet Gynecol Scand; 2009 Feb 15; 88(1):18-26. PubMed ID: 19023702
    [Abstract] [Full Text] [Related]

  • 28. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Dai Y, Hu C, Wang L, Huang Y, Zhang L, Xiao X, Tan Y.
    Scand J Rheumatol; 2010 May 15; 39(3):240-6. PubMed ID: 20166849
    [Abstract] [Full Text] [Related]

  • 29. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC, Wang G, Ng JK, Kwan BC, Mac-Moune Lai F, Chow KM, Luk CC, Lai KB, Li PK.
    BMC Nephrol; 2019 Mar 04; 20(1):77. PubMed ID: 30832601
    [Abstract] [Full Text] [Related]

  • 30. Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients.
    Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G.
    Appl Biochem Biotechnol; 2009 Oct 04; 159(1):221-32. PubMed ID: 19145410
    [Abstract] [Full Text] [Related]

  • 31. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
    Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H.
    Kidney Int; 2005 Jun 04; 67(6):2313-20. PubMed ID: 15882273
    [Abstract] [Full Text] [Related]

  • 32. Comprehensive analysis of short peptides in sera from patients with IgA nephropathy.
    Kaneshiro N, Xiang Y, Nagai K, Kurokawa MS, Okamoto K, Arito M, Masuko K, Yudoh K, Yasuda T, Suematsu N, Kimura K, Kato T.
    Rapid Commun Mass Spectrom; 2009 Dec 04; 23(23):3720-8. PubMed ID: 19902551
    [Abstract] [Full Text] [Related]

  • 33. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP.
    Arthritis Rheum; 2005 Dec 04; 52(12):3801-12. PubMed ID: 16320331
    [Abstract] [Full Text] [Related]

  • 34. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J, Syrjänen J, Helin H, Pasternack A, Kattainen A, Mustonen J.
    Nephrol Dial Transplant; 2006 Jul 04; 21(7):1876-82. PubMed ID: 16522659
    [Abstract] [Full Text] [Related]

  • 35. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer.
    Padoan A, Seraglia R, Basso D, Fogar P, Sperti C, Moz S, Greco E, Marchet A, de Manzoni G, Zambon CF, Navaglia F, Cristadoro L, Di Chiara A, Nitti D, Pedrazzoli S, Pavanello G, Plebani M.
    Pancreas; 2013 May 04; 42(4):622-32. PubMed ID: 23271396
    [Abstract] [Full Text] [Related]

  • 36. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J.
    J Biomed Nanotechnol; 2012 Feb 04; 8(1):133-9. PubMed ID: 22515101
    [Abstract] [Full Text] [Related]

  • 37. Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity.
    Zhang JJ, Jiang L, Liu G, Wang SX, Zou WZ, Zhang H, Zhao MH.
    Scand J Immunol; 2009 May 04; 69(5):457-64. PubMed ID: 19508377
    [Abstract] [Full Text] [Related]

  • 38. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A.
    Rapid Commun Mass Spectrom; 2007 May 04; 21(24):4142-8. PubMed ID: 18022963
    [Abstract] [Full Text] [Related]

  • 39. Serum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technology.
    Xi L, Junjian Z, Yumin L, Yunwen L, Hongbin W.
    Neurosci Lett; 2009 Sep 29; 463(1):6-11. PubMed ID: 19631719
    [Abstract] [Full Text] [Related]

  • 40. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L.
    Neurology; 2006 Apr 25; 66(8):1218-22. PubMed ID: 16481598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.